RhythmAnalytics vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RhythmAnalytics

by Biofourmis

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

RhythmAnalytics specializes in the automated interpretation of cardiac arrhythmias from ECG data, providing clinical decision support for rhythm disorders. Autoplaque, on the other hand, focuses on quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction. While both are FDA-cleared AI tools in cardiology, they address distinct diagnostic areas and utilize different data inputs, making them complementary rather than direct competitors.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data. This tool is ideal for enhancing clinical decision support in scenarios involving continuous or intermittent ECG monitoring, such as remote patient monitoring or emergency medicine, where rapid and accurate arrhythmia detection is crucial.

View RhythmAnalytics →

Choose Autoplaque if…

Choose Autoplaque if you require advanced, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is best suited for cardiologists and radiologists who need detailed anatomical insights for heart attack risk prediction and guiding treatment strategies based on the extent and characteristics of coronary artery disease.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RhythmAnalytics	Autoplaque
Pricing	Contact vendor	Unknown
Deployment	Cloud-based API	Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RhythmAnalytics

RhythmAnalytics offers a cloud-based API designed for seamless integration into existing clinical workflows and medical devices, which generally provides a more integrated user experience. Its broader platform includes patient and clinician apps, further enhancing accessibility. Autoplaque, being workstation-based, may require clinicians to operate a separate application, potentially adding friction to their workflow.

Clinical Value

Tie

Both tools are FDA-cleared and deliver substantial clinical value in distinct areas of cardiology. RhythmAnalytics provides critical real-time decision support for cardiac arrhythmias from ECG data, while Autoplaque offers in-depth quantitative analysis of coronary plaques from CT angiography for heart attack risk prediction and treatment guidance. Their applications are complementary, addressing different but equally important clinical needs.

Pricing & Value

Tie

Neither RhythmAnalytics nor Autoplaque provides transparent, publicly disclosed pricing information. Without specific pricing details for either tool, it is impossible to conduct a meaningful comparison of their respective value propositions or determine a winner in this dimension.

Enterprise Readiness

RhythmAnalytics

RhythmAnalytics demonstrates stronger enterprise readiness with its cloud-based API deployment and explicit HIPAA compliance. This architecture facilitates easier integration into large healthcare IT environments and EMR systems. Autoplaque's workstation-based deployment and unspecified HIPAA compliance in the provided facts present potential challenges for broad enterprise adoption.

Innovation

Tie

Both tools represent significant innovation by applying AI to complex diagnostic challenges in cardiology. RhythmAnalytics leverages enhanced deep learning for highly accurate, automated interpretation of numerous cardiac arrhythmias via a scalable cloud API. Autoplaque offers advanced quantitative analysis of coronary plaque from CT angiography, a crucial step for personalized risk assessment, and its technology has been licensed by HeartFlow. Both contribute cutting-edge AI solutions.

Support & Docs

Autoplaque

While extensive details on support are lacking for both, the FDA document for Autoplaque explicitly mentions the existence of a 'user manual' that specifies minimum hardware requirements. This indicates a level of formal documentation available for Autoplaque. No similar explicit mention of a user manual or detailed documentation was found for RhythmAnalytics in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RhythmAnalytics	Autoplaque
Name	RhythmAnalytics	Autoplaque
Company	Biofourmis Singapore Pte.	Cedars-Sinai Medical Center: AIM
Primary Data Input	single-lead ECG data	CT angiography images
Core Functionality	AI-powered automated interpretation of cardiac arrhythmias	AI-powered quantitative analysis of coronary plaques and luminal stenoses
Specific Detections/Measurements	Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats); Beat-by-beat morphology computation; QRS and Ventricular Ectopic Beat detection; QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis	Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology; Automated vessel, plaque, and lumen segmentation

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Autoplaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What type of cardiac data does each tool analyze?

RhythmAnalytics by Biofourmis analyzes single-lead ECG data for automated interpretation of cardiac arrhythmias. Autoplaque by Cedars-Sinai AIM analyzes CT angiography images for quantitative analysis of coronary plaques and luminal stenoses.

What are the primary clinical applications or purposes of each tool?

RhythmAnalytics provides AI-powered automated interpretation of cardiac arrhythmias for enhanced clinical decision support. Autoplaque offers AI-powered quantitative analysis for coronary plaque and stenosis, aiding in heart attack risk prediction and treatment guidance.

Which medical specialties are these tools designed to support?

RhythmAnalytics is designed for Cardiology, Emergency Medicine, and Internal Medicine. Autoplaque is designed for Cardiology and Radiology.

What specific types of cardiac conditions or findings does each tool help detect or analyze?

RhythmAnalytics detects over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats, along with QRS feature extraction and rhythm analysis. Autoplaque detects and characterizes coronary artery plaque and measures luminal stenoses from CT Angiographic images, including automated vessel, plaque, and lumen segmentation.

Does either tool offer integration capabilities with existing medical devices or systems?

RhythmAnalytics is a cloud-based API compatible with FDA-cleared ECG devices such as Holter, event recorders, and wearable sensors. Autoplaque is a workstation-based post-processing application, with its deployment focused on running on standard computer platforms.